NASDAQ:JANX

Janux Therapeutics Stock Insider Trading

etoro logo Buy JANX
*Your capital is at risk
$13.59
-0.190 (-1.38%)
At Close: Jun 03, 2026

Janux Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 90.43. In total, the insiders bought 3.66M and sold 57.74K JANX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
90.43
Buy 3.66M shares
Sell 57.74K shares
83% Buy Activity
Strong Negative Correlation
Buy Signal High Confidence
Jun 01, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 90.43.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (83% buys).

Historical Insider Trades

Date Type Person Role Amount
May 11, 2026
Sell
Common Stock
S-Sale
Dobek Maria
Vice President, Accounting
CEO / President 2 038
Value: $28.9K
Feb 02, 2026
Buy
Stock option (right to buy)
A-Award
Go William
Chief Medical Officer
Officer 154 000
Value: $2.15M
Feb 02, 2026
Buy
Common Stock
A-Award
Go William
Chief Medical Officer
Officer 44 000
Value: $615.6K
Jan 26, 2026
Buy
Common Stock
J-Other
Go William
Insider
Other 0
Value: $0
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Dobek Maria
Vice President, Accounting
CEO / President 42 600
Value: $581.5K
Jan 02, 2026
Buy
Common Stock
A-Award
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Officer 36 000
Value: $491.4K
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Officer 126 000
Value: $1.72M
Jan 02, 2026
Sell
Common Stock
S-Sale
Mciver Zachariah
Chief Medical Officer
Officer 2 714
Value: $37.3K
Jan 02, 2026
Buy
Common Stock
A-Award
Mciver Zachariah
Chief Medical Officer
Officer 29 000
Value: $395.9K
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Campbell David Alan
President And CEO
CEO / President 338 100
Value: $4.62M
Jan 02, 2026
Sell
Common Stock
S-Sale
Meyer Andrew Hollman
Chief Business Officer
Officer 1 879
Value: $25.8K
Jan 02, 2026
Buy
Common Stock
A-Award
Diraimondo Thomas
Chief Scientific Officer
Officer 31 400
Value: $428.6K
Jan 02, 2026
Sell
Common Stock
S-Sale
Diraimondo Thomas
Chief Scientific Officer
Officer 2 505
Value: $34.4K
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Diraimondo Thomas
Chief Scientific Officer
Officer 109 900
Value: $1.50M
Jan 02, 2026
Buy
Common Stock
A-Award
Campbell David Alan
President And CEO
CEO / President 96 600
Value: $1.32M
Jan 02, 2026
Sell
Common Stock
S-Sale
Campbell David Alan
President And CEO
CEO / President 8 072
Value: $110.8K
Jan 02, 2026
Buy
Common Stock
A-Award
Dobek Maria
Vice President, Accounting
CEO / President 18 935
Value: $258.5K
Jan 02, 2026
Buy
Common Stock
A-Award
Winter Charles M.
Chief Technical Officer
Officer 28 600
Value: $390.4K
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Winter Charles M.
Chief Technical Officer
Officer 100 100
Value: $1.37M
Jan 02, 2026
Sell
Common Stock
S-Sale
Winter Charles M.
Chief Technical Officer
Officer 2 401
Value: $33.0K
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Mciver Zachariah
Chief Medical Officer
Officer 101 500
Value: $1.39M
Jan 02, 2026
Sell
Common Stock
S-Sale
Dobek Maria
Vice President, Accounting
CEO / President 1 462
Value: $20.1K
Dec 01, 2025
Buy
Stock Option (right to buy)
M-Exempt
Meyer Andrew Hollman
Chief Business Officer
Officer 3 333
Value: $35.3K
Dec 01, 2025
Buy
Common Stock
M-Exempt
Meyer Andrew Hollman
Chief Business Officer
Officer 3 333
Value: $35.3K
Dec 01, 2025
Sell
Common Stock
S-Sale
Meyer Andrew Hollman
Chief Business Officer
Officer 2 700
Value: $88.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT JANUX THERAPEUTICS, INC.
Janux Therapeutics
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE